Standard Treatment Guidelines for Common Illness of Adults in Papua New Guinea

Objectives

Provide national standard treatment guidance for common adult illnesses in Papua New Guinea, supporting nurses, Health Extension Officers and doctors to deliver safe, appropriate and cost-effective care through standard treatments unless professional reasons justify an alternative.[1]The manual is organised as a practical clinical framework spanning general management, emergencies and major disease-specific conditions, rather than as a separate health-policy strategy.[2][3]

• Promote consistent diagnosis, treatment, follow-up and referral across health services, with particular emphasis on urgent management of anaphylaxis, burns, poisoning, shock, trauma, severe infections and other life-threatening presentations.[4][5][6][7]
• Update treatment recommendations in response to changing disease patterns and antimicrobial resistance, drawing on local evidence from the National Department of Health and the Papua New Guinea Institute of Medical Research.[8]
• Incorporate disease-specific guidance for malaria, tuberculosis, human immunodeficiency virus infection and acquired immunodeficiency syndrome, and diabetes, while directing health workers to the relevant specialist guidance for detailed management.[8][9]
• Prevent complications and deaths through prompt treatment, clinical observation, clear escalation thresholds, patient education and referral where local capacity or treatment response is inadequate.[5][10][11]
• Strengthen tuberculosis control through Directly Observed Treatment Short-course, with targets of a cure rate above 85% among new positive cases and case detection above 70% of estimated new positive cases.[12][13]
• Support prevention alongside treatment, including childhood hepatitis B immunisation, lifestyle measures for diabetes and hypertension, safer sex and HIV counselling, household contact management for tuberculosis and leprosy, and hygiene, safe water and vector-related measures where relevant.[14][15][16][17][18][19]

The available material does not set out a single overarching mission statement, formal strategic framework, implementation targets or document-wide areas of action beyond the clinical purpose and condition-specific guidance.[1][2][20]

Implementation

Implement the manual through routine health-worker training, integration with the medical supply system and use across Papua New Guinea health services.[1]Delivery relies on structured clinical assessment, standard first- and second-line treatment pathways, diagnostic testing where available, patient counselling, documentation, review and referral to medical officers, specialists or designated disease-control personnel when indicated.[8][21][22]

• Use National Department of Health-endorsed, locally and internationally developed disease-specific guidelines alongside the manual, including the National Protocol for Malaria Treatment and comprehensive clinical guidance for diabetes and HIV management.[8][9][16]
• Apply diagnostic-led care, including malaria blood slides or rapid diagnostic tests, sputum microscopy for tuberculosis, laboratory and imaging investigations where available, and syndrome-based management for sexually transmitted infections where a definitive diagnosis is not required before treatment.[23][16][13]
• Deliver emergency care through immediate stabilisation of airway, breathing and circulation, provision of oxygen, fluids, medicines and supportive care, and transfer with treatment continuing when higher-level assessment or intervention is needed.[6][11][24]
• Operate referral pathways for severe illness, treatment failure, diagnostic uncertainty, medicine adverse effects, pregnancy-related risks and cases requiring surgery, specialist review, blood transfusion or advanced investigation.[25][26][27]
• Establish diabetes clinics within the health-care system where absent, using appropriately trained staff and well-designed protocols, and support self-management through education, dietary management, physical activity, weight control and family involvement.[9][28][29]
• Implement tuberculosis services through political and community support, sputum microscopy, directly observed treatment, reliable medicine supplies, treatment cards, registration books, health-worker or trained treatment-partner supervision, and a tuberculosis information system for recording, monitoring, reporting and evaluation.[12][13]
• Engage the National Department of Health, Papua New Guinea Institute of Medical Research, Society of Physicians, clinical discipline chiefs, local and international experts, World Health Organization and frontline health workers in technical development and updating.[1][8]
• Support condition-specific surveillance and notification, including notification of unusually high diarrhoea or dysentery caseloads to the Provincial Health Adviser, confirmed typhoid to the provincial disease control officer, yaws to the Provincial Disease Control Officer, and acute flaccid paralysis for polio surveillance.[30][31][32][33]
• Use annexed operational tools, including the Glasgow Coma Scale, tuberculosis dosing references, laboratory reference intervals, malaria rapid diagnostic testing procedures, asthma spacer instructions, artesunate injection preparation and Body Mass Index calculation.[34][35][20]

Clinical monitoring is embedded in many pathways, such as repeated assessment of hydration, urine output, blood pressure, treatment response, adverse reactions, blood glucose, sputum results and disease-specific follow-up.[5][36][37][38][19]However, apart from the tuberculosis information system and specified disease notifications, the material does not specify a document-wide governance structure, implementation timetable, financing plan, workforce model or comprehensive performance-management framework.[12][13][20]

Monitoring & Evaluation

The manual primarily relies on clinical monitoring, reassessment, referral thresholds and disease-specific registers rather than a unified document-level monitoring and evaluation framework. Formal indicators, reporting schedules, surveillance arrangements and accountability mechanisms are generally not specified outside tuberculosis, communicable-disease notifications and selected clinical programmes.[1][12][13][20]

• Use local antimicrobial-resistance evidence from the National Department of Health and the Papua New Guinea Institute of Medical Research to update treatment recommendations, supported by diagnostic annexes and clinical reference tools.[8][34][35]
• Monitor acute treatment response through repeated clinical observations, including adrenaline response in anaphylaxis, urine output and fluid balance in burns or shock, vital signs during transfer, and blood glucose, haemoglobin, consciousness and urine output in severe malaria.[4][5][6][10][11]
• Apply condition-specific reassessment and referral triggers, including non-response to antibiotics, persistent fever, deteriorating respiratory status, recurrent symptoms, uncontrolled pain, treatment failure and suspected complications.[25][39][40][24][18]
• Maintain clinical records where required, including morphine and pethidine dosage records, burn diagrams, diabetes weight-progress records, and patient education or treatment documentation.[5][29]
• Use diagnostic testing to guide management, including malaria microscopy or rapid diagnostic tests, tuberculosis sputum testing, whole-blood clotting tests for snakebite, laboratory testing for meningitis and targeted investigations for hypertension, liver disease and anaemia.[41][26][16][42][43]
• Notify public-health authorities of unusual diarrhoea or dysentery clusters, confirmed typhoid, acute flaccid paralysis and yaws; maintain surveillance for acute flaccid paralysis to preserve Papua New Guinea’s polio-free status.[30][31][33]
• Implement the Directly Observed Treatment Short-course tuberculosis information system to record, monitor, report and evaluate control activities, supported by treatment cards, registration books and TB officer oversight.[12][13]
• Track tuberculosis performance against a cure rate above 85% among new positive cases and a case-detection rate above 70% of estimated new positive cases; supervise each dose, collect follow-up sputum at two, four and six months, and define treatment failure as persistent sputum positivity after five months.[13][38][27]
• Monitor leprosy through six-monthly smears, adverse-effect checks, treatment-completion deadlines, defaulter tracing and referral to Tuberculosis or Leprosy Officers where treatment response is inadequate.[18][19]
• Recognise gaps in routine service monitoring, including the stated challenge that diabetic-retinopathy and neuropathy screening is not currently available or recommended as routine examination in Papua New Guinea.[28]

Costing & Financing

Financing information is limited. The manual promotes cost-effective standard treatment and links guidance to the medical supply system, while the World Health Organization provided editorial assistance and funding for the manual; however, no overall budget, programme costing, allocation, funding gap, resource-mobilisation plan or economic assumptions are specified.[1][8]

• Align standard treatment guidance with health-worker training curricula and the medical supply system, indicating that medicine availability and supply-chain support are implementation requirements.[1]
• Recognise adequate funding, political commitment, community support and reliable supplies of all tuberculosis medicines as critical requirements for Directly Observed Treatment Short-course implementation.[12]
• Provide fixed-dose combination tuberculosis medicines, diagnostic capacity, treatment cards, registration systems, supervised treatment and referral pathways, although no associated financial values are given.[12][13][38]
• Identify clinical resource needs across the manual, including medicines, oxygen, intravenous fluids, laboratory tests, blood products, catheters, dressings, antivenom, malaria diagnostics and referral transport, without pricing or budget allocations.[44][45][10][32][40]
• Use dietary change and increased physical activity as the most economical means of weight loss in diabetes care, without quantifying savings, costs or affordability assumptions.[29]
• Note external support from the World Diabetes Foundation for development of comprehensive diabetes clinical guidelines, with no monetary contribution stated.[9]
• Recognise that most condition-specific sections specify treatment inputs and durations but do not provide costs, financing sources, funding gaps or implementation budgets.[4][46][17][20]